Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
Am J Nephrol. 2018;47(5):304-316. doi: 10.1159/000488946. Epub 2018 May 18.
Chronic kidney disease (CKD) is a rapidly growing, worldwide public health problem. Recent advances in genome-wide-association studies (GWAS) revealed several genetic loci associated with renal function traits worldwide.
We investigated the association of genetic factors with the levels of serum creatinine (SCr) and the estimated glomerular filtration rate (eGFR) in Japanese population-based cohorts analyzing the GWAS imputed data with 11,221 subjects and 12,617,569 variants, and replicated the findings with the 148,829 hospital-based Japanese subjects.
In the discovery phase, 28 variants within 4 loci (chromosome [chr] 2 with 8 variants including rs3770636 in the LDL receptor related protein 2 gene locus, on chr 5 with 2 variants including rs270184, chr 17 with 15 variants including rs3785837 in the BCAS3 gene locus, and chr 18 with 3 variants including rs74183647 in the nuclear factor of -activated T-cells 1 gene locus) reached the suggestive level of p < 1 × 10-6 in association with eGFR and SCr, and 2 variants on chr 4 (including rs78351985 in the microsomal triglyceride transfer protein gene locus) fulfilled the suggestive level in association with the risk of CKD. In the replication phase, 25 variants within 3 loci (chr 2 with 7 variants, chr 17 with 15 variants and chr 18 with 3 variants) in association with eGFR and SCr, and 2 variants on chr 4 associated with the risk of CKD became nominally statistically significant after Bonferroni correction, among which 15 variants on chr 17 and 3 variants on chr 18 reached genome-wide significance of p < 5 × 10-8 in the combined study meta-analysis. The associations of the loci on chr 2 and 18 with eGFR and SCr as well as that on chr 4 with CKD risk have not been previously reported in the Japanese and East Asian populations.
Although the present GWAS of renal function traits included the largest sample of Japanese participants to date, we did not identify novel loci for renal traits. However, we identified the novel associations of the genetic loci on chr 2, 4, and 18 with renal function traits in the Japanese population, suggesting these are transethnic loci. Further investigations of these associations are expected to further validate our findings for the potential establishment of personalized prevention of renal disease in the Japanese and East Asian populations.
慢性肾脏病(CKD)是一个迅速发展的全球性公共卫生问题。全基因组关联研究(GWAS)的最新进展揭示了全球范围内与肾功能相关的几个遗传位点。
我们分析了日本人群队列 GWAS 导入数据,在 11221 名受试者和 12617569 个变体中研究了遗传因素与血清肌酐(SCr)和估计肾小球滤过率(eGFR)水平的关联,并在 148829 名基于医院的日本受试者中复制了这些发现。
在发现阶段,4 个位点(2 号染色体上有 8 个变异,包括 LDL 受体相关蛋白 2 基因座上的 rs3770636,5 号染色体上有 2 个变异,包括 rs270184,17 号染色体上有 15 个变异,包括 BCAS3 基因座上的 rs3785837,18 号染色体上有 3 个变异,包括核因子激活 T 细胞 1 基因座上的 rs74183647)中的 28 个变异与 eGFR 和 SCr 相关,达到了 p < 1 × 10-6 的暗示水平,而 4 号染色体上的 2 个变异(包括 microsomal triglyceride transfer protein 基因座上的 rs78351985)与 CKD 风险相关,达到了 p < 1 × 10-6 的暗示水平。在复制阶段,与 eGFR 和 SCr 相关的 3 个位点(2 号染色体上有 7 个变异,17 号染色体上有 15 个变异,18 号染色体上有 3 个变异)和与 CKD 风险相关的 4 号染色体上的 2 个变异在经过 Bonferroni 校正后达到了名义统计学意义,其中 17 号染色体上的 15 个变异和 18 号染色体上的 3 个变异在联合研究荟萃分析中达到了全基因组显著水平(p < 5 × 10-8)。2 号染色体和 18 号染色体上的位点与 eGFR 和 SCr 以及 4 号染色体上的位点与 CKD 风险之间的关联以前在日本和东亚人群中没有报道过。
尽管目前的肾功能特征全基因组关联研究包括了迄今为止最大的日本参与者样本,但我们没有发现与肾脏特征相关的新位点。然而,我们在日本人群中发现了与 2 号、4 号和 18 号染色体上的遗传位点与肾功能特征相关的新关联,这表明这些是跨种族的位点。对这些关联的进一步研究有望进一步验证我们的发现,为日本和东亚人群潜在的肾脏疾病个体化预防奠定基础。